Benjamin A. Nacev

2.2k total citations
34 papers, 1.2k citations indexed

About

Benjamin A. Nacev is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Benjamin A. Nacev has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Benjamin A. Nacev's work include Sarcoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (6 papers) and Protein Degradation and Inhibitors (5 papers). Benjamin A. Nacev is often cited by papers focused on Sarcoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (6 papers) and Protein Degradation and Inhibitors (5 papers). Benjamin A. Nacev collaborates with scholars based in United States, Italy and Canada. Benjamin A. Nacev's co-authors include Jun O. Liu, C. David Allis, Tom W. Muir, Lijuan Feng, John D. Bagert, Qing Xiao, Feiran Zhang, Dehua Pei, Jianjiong Gao and Ritika Kundra and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Benjamin A. Nacev

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin A. Nacev United States 15 881 322 184 182 98 34 1.2k
Lluís López-Barcons United States 16 742 0.8× 305 0.9× 186 1.0× 188 1.0× 103 1.1× 44 1.3k
Britta Stordal Ireland 15 665 0.8× 637 2.0× 228 1.2× 129 0.7× 77 0.8× 30 1.3k
Punit Saraon Canada 19 805 0.9× 236 0.7× 267 1.5× 240 1.3× 99 1.0× 25 1.5k
Vladimir Khazak United States 20 985 1.1× 298 0.9× 150 0.8× 113 0.6× 140 1.4× 34 1.2k
Ben Allal France 20 489 0.6× 347 1.1× 139 0.8× 132 0.7× 56 0.6× 32 918
Birgitte Brinkmann Olsen Denmark 20 691 0.8× 291 0.9× 95 0.5× 115 0.6× 99 1.0× 53 1.1k
Olivier Reelfs United Kingdom 15 594 0.7× 373 1.2× 139 0.8× 131 0.7× 68 0.7× 20 977
Sandra Muñoz-Galván Spain 18 661 0.8× 387 1.2× 215 1.2× 103 0.6× 132 1.3× 40 1.0k
Jian An China 17 1.1k 1.3× 413 1.3× 299 1.6× 279 1.5× 95 1.0× 37 1.5k

Countries citing papers authored by Benjamin A. Nacev

Since Specialization
Citations

This map shows the geographic impact of Benjamin A. Nacev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin A. Nacev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin A. Nacev more than expected).

Fields of papers citing papers by Benjamin A. Nacev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin A. Nacev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin A. Nacev. The network helps show where Benjamin A. Nacev may publish in the future.

Co-authorship network of co-authors of Benjamin A. Nacev

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin A. Nacev. A scholar is included among the top collaborators of Benjamin A. Nacev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin A. Nacev. Benjamin A. Nacev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benhamida, Jamal, Laetitia Borsu, Liliana Villafania, et al.. (2025). Methylation Analysis Reveals Epigenetic Congruence Between Bone Sarcomas With H3-3A Mutations and Malignant Giant Cell Tumors of Bone. Modern Pathology. 38(7). 100763–100763. 1 indexed citations
2.
Yan, Fang, Douglas Barrows, Thomas S. Carroll, et al.. (2024). ATRX guards against aberrant differentiation in mesenchymal progenitor cells. Nucleic Acids Research. 52(9). 4950–4968. 3 indexed citations
3.
Nacev, Benjamin A., Matthew R. Paul, Michelle M. Mitchener, et al.. (2024). Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation. Nature Communications. 15(1). 5155–5155. 4 indexed citations
4.
Rosenbaum, Evan, Kenneth Seier, Martina Bradić, et al.. (2023). Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas. Cancer Research Communications. 3(10). 2118–2125. 6 indexed citations
5.
Lebow, Emily S., Stephanie Lobaugh, Zhigang Zhang, et al.. (2023). Stereotactic body radiation therapy for sarcoma pulmonary metastases. Radiotherapy and Oncology. 187. 109824–109824. 4 indexed citations
6.
Dermawan, Josephine K., Samuel Singer, William D. Tap, et al.. (2022). The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms. Modern Pathology. 35(12). 1900–1909. 17 indexed citations
7.
Angeles, Christina V., David Shum, Penelope D. Ruiz, et al.. (2021). A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma. Clinical Cancer Research. 28(1). 175–186. 10 indexed citations
8.
Bagert, John D., Michelle M. Mitchener, Barbara E. Dul, et al.. (2021). Oncohistone mutations enhance chromatin remodeling and alter cell fates. Nature Chemical Biology. 17(4). 403–411. 58 indexed citations
9.
Rosenbaum, Evan, Kenneth Seier, Chaitanya Bandlamudi, et al.. (2020). HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome. Clinical Cancer Research. 26(20). 5448–5455. 12 indexed citations
10.
Nacev, Benjamin A., Kevin B. Jones, Andrew M. Intlekofer, et al.. (2020). The epigenomics of sarcoma. Nature reviews. Cancer. 20(10). 608–623. 138 indexed citations
11.
Rosenbaum, Evan, Philip Jonsson, Kenneth Seier, et al.. (2020). Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes. JCO Precision Oncology. 4(4). 1350–1360. 26 indexed citations
12.
Noch, Evan, Benjamin A. Nacev, Jason Yongsheng Chan, et al.. (2019). A 43 year-old woman with primary central nervous system angiosarcoma with CIC-LEUTX gene rearrangement (P3.6-017). Neurology. 92(15_supplement). 3 indexed citations
13.
Nacev, Benjamin A., Lijuan Feng, John D. Bagert, et al.. (2019). The expanding landscape of ‘oncohistone’ mutations in human cancers. Nature. 567(7749). 473–478. 257 indexed citations
14.
Crompton, Joseph G., Benjamin A. Nacev, Saïd C. Azoury, et al.. (2014). Traumatic ventricular septal defect resulting in severe pulmonary hypertension. Journal of Surgical Case Reports. 2014(10). rju107–rju107. 1 indexed citations
15.
Wilson, Brice A. P., Haofan Wang, Benjamin A. Nacev, et al.. (2011). High-Throughput Screen Identifies Novel Inhibitors of Cancer Biomarker α-Methylacyl Coenzyme A Racemase (AMACR/P504S). Molecular Cancer Therapeutics. 10(5). 825–838. 44 indexed citations
16.
Nacev, Benjamin A., Tina Tianjiao Su, Su Zhuang, et al.. (2011). A Calcineurin-Independent Mechanism of Angiogenesis Inhibition by a Nonimmunosuppressive Cyclosporin A Analog. Journal of Pharmacology and Experimental Therapeutics. 338(2). 466–475. 21 indexed citations
17.
Nacev, Benjamin A. & Jun O. Liu. (2011). Synergistic Inhibition of Endothelial Cell Proliferation, Tube Formation, and Sprouting by Cyclosporin A and Itraconazole. PLoS ONE. 6(9). e24793–e24793. 28 indexed citations
18.
Shim, Joong Sup, Yoshiyuki Matsui, Shridhar Bhat, et al.. (2010). Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer. JNCI Journal of the National Cancer Institute. 102(24). 1855–1873. 95 indexed citations
19.
Xiao, Qing, Feiran Zhang, Benjamin A. Nacev, Jun O. Liu, & Dehua Pei. (2010). Protein N-Terminal Processing: Substrate Specificity of Escherichia coli and Human Methionine Aminopeptidases. Biochemistry. 49(26). 5588–5599. 153 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lluís López-Barcons Breakdown of academic impact, for papers by Britta Stordal Breakdown of academic impact, for papers by Punit Saraon Breakdown of academic impact, for papers by Vladimir Khazak Breakdown of academic impact, for papers by Ben Allal Breakdown of academic impact, for papers by Birgitte Brinkmann Olsen Breakdown of academic impact, for papers by Olivier Reelfs Breakdown of academic impact, for papers by Sandra Muñoz-Galván Breakdown of academic impact, for papers by Jian An
Rankless by CCL
2026